Chemically treated plasma Aβ is a potential blood-based biomarker for screening cerebral amyloid deposition

Annexin A1 restores Aβ1-42-induced blood-brain barrier disruption through the inhibition of RhoA-ROCK signaling pathway

(2016) Jong-Chan Park et al.   AGING CELL

PiB-PET Imaging-Based Serum Proteome Profiles Predict Mild Cognitive Impairment and Alzheimer’s Disease

(2016) Seokjo Kang et al.   JOURNAL OF ALZHEIMERS DISEASE

Amyloid β-interacting partners in Alzheimer's disease: From accomplices to possible therapeutic targets

(2016) Sun-Ho Han et al.   PROGRESS IN NEUROBIOLOGY

Prevalence of Amyloid PET Positivity in Dementia Syndromes

(2015) Rik Ossenkoppele et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Prevalence of Cerebral Amyloid Pathology in Persons Without Dementia

(2015) Willemijn J. Jansen et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

NMR metabolomics profiling of blood plasma mimics shows that medium- and long-chain fatty acids differently release metabolites from human serum albumin

(2013) M. Jupin et al.   JOURNAL OF MAGNETIC RESONANCE

Neuropathological Alterations in Alzheimer Disease

(2013) A. Serrano-Pozo et al.   Cold Spring Harbor Perspectives in Medicine

Proteolytic Degradation of Amyloid  -Protein

(2013) T. Saido et al.   Cold Spring Harbor Perspectives in Medicine

Stability of amyloid-β peptides in plasma and serum

(2012) Mirko Bibl et al.   ELECTROPHORESIS

Phosphorylation of Amyloid-β Peptide at Serine 8 Attenuates Its Clearance via Insulin-degrading and Angiotensin-converting Enzymes

(2012) Sathish Kumar et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Coordinated Analysis of Age, Sex, and Education Effects on Change in MMSE Scores

(2012) A. M. Piccinin et al.   JOURNALS OF GERONTOLOGY SERIES B-PSYCHOLOGICAL SCIENCES AND SOCIAL SCIENCES

Global Stability of Plasma Proteomes for Mass Spectrometry-Based Analyses

(2012) Lisa J. Zimmerman et al.   MOLECULAR & CELLULAR PROTEOMICS

Synapses and Alzheimer's Disease

(2012) M. Sheng et al.   Cold Spring Harbor Perspectives in Biology

Current and future treatments for Alzheimer’s disease

(2012) Konstantina G. Yiannopoulou et al.   Therapeutic Advances in Neurological Disorders

The diagnosis of dementia due to Alzheimer’s disease: Recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer's disease

(2011) Guy M. McKhann et al.   Alzheimers & Dementia

Stoichiometry and Affinity of the Human Serum Albumin-Alzheimer's Aβ Peptide Interactions

(2011) Julijana Milojevic et al.   BIOPHYSICAL JOURNAL

Diet and Alzheimer’s disease risk factors or prevention: the current evidence

(2011) Vincenzo Solfrizzi et al.   Expert Review of Neurotherapeutics

Association of Plasma β-Amyloid Level and Cognitive Reserve With Subsequent Cognitive Decline

(2011) Kristine Yaffe   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Human serum albumin: From bench to bedside

(2011) Gabriella Fanali et al.   MOLECULAR ASPECTS OF MEDICINE

Amyloid β peptides in plasma in early diagnosis of Alzheimer's disease: A multicenter study with multiplexing

(2009) P. Lewczuk et al.   EXPERIMENTAL NEUROLOGY

Soluble aggregates of the amyloid-β peptide are trapped by serum albumin to enhance amyloid-β activation of endothelial cells

(2009) Adriana A Reyes Barcelo et al.   Journal of Biological Engineering

Plasma amyloid levels and the risk of AD in normal subjects in the Cardiovascular Health Study

(2008) O. L. Lopez et al.   NEUROLOGY

Conversion from cognitive health to mild cognitive impairment and Alzheimer's disease: Prediction by plasma amyloid beta 42, medial temporal lobe atrophy and homocysteine

(2006) Imrich Blasko et al.   NEUROBIOLOGY OF AGING